Desmopressin and bleeding during invasive surgery

European Journal of Anaesthesiology, Supplement

Volumn 14, Issue 4, 1997, Pages 42-49

  Hunt, B J ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Anaesthetic technique, cardio pulmonary bypass; Blood, loss; Complications, haemorrhage; Pharmacology, desmopressin; Surgery, cardiovascular

Indexed keywords

DESMOPRESSIN; VASOPRESSIN DERIVATIVE;

BLEEDING; BLEEDING TENDENCY; BLOOD TRANSFUSION; CARDIOPULMONARY BYPASS; CONFERENCE PAPER; DRUG EFFICACY; HEMOPHILIA A; HEMOSTASIS; HUMAN; INFECTION; OPEN HEART SURGERY; PREOPERATIVE EVALUATION; VON WILLEBRAND DISEASE;

BLOOD LOSS, SURGICAL; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DEAMINO ARGININE VASOPRESSIN; HEMOSTATICS; HUMANS;

EID: 0030728174     PISSN: 09521941     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003643-199703001-00009     Document Type: Article

References (30)

1. Aledort LM. New approaches to management of bleeding disorders. Hosp Pract 1989; 207-226.
2. Mammen EF, Korpman RA, Huse WM, Vriggs BD. Haemostatic changes during cardiopulmonary bypass. Sem Thromb Haem 1985; 11: 281-292.
3. Harker LA. Bleeding after cardiopulmonary bypass. New Engl J Med 1986; 314: 1446-1448.
4. Hunt BJ, Yacoub MH. Aprotinin and cardiac surgery. Br Med J 1991; 303: 660-661.
5. Holloway DS, Summaria L, Sandesara J, Vagher JP, Alexander JC, Capronon JA. Decreased platelet number and function and increased fibrinolysis contribute to postoperative bleeding in cardiopulmonary bypass patients. Thromb Haemost 1988; 59: 62-67.
6. Burns ER, Billett H, Fraser RM, Sisto DA. The pre-operative bleeding time as a predictor of postoperative haemorrhage after cardiopulmonary bypass. J Thorac Cardiovasc Surg 1986; 92: 310-312.
7. Salzman EW, Weinstein MJ, Weinstein RM et al. Treatment with desmopressin acetate to reduce blood loss after cardiac surgery: A double-blind randomized trial. New Engl J Med 1986; 314: 1402-1406.
8. Holdwright DR, Hunt BJ, Parratt R et al. The effect of cardiopulmonary bypass on systemic and coronary levels of von Willebrand Factor. Eur J Cardiothorac Surg 1995; 9: 18-21.
9. Kuitunen A, Hynynen M, Salmenperä M et al. Anaesthesia affects plasma concentrations of vasopressin, von Willebrand Factor and coagulation factor VIII in cardiac surgical patients. Br J Anaesth 1993; 70: 173-180.
10. Czer LSC, Bateman TM, Gray RJ et al. Treatment of severe platelet dysfunction and hemorrhage after cardiopulmonary bypass: reduction in product usage with desmopressin. J Am Coll Cardiol 1987; 9: 1139-1147.
11. Hackmann TM, Gascoyne RD, Naiman SC et al. A trial of desmopressin (1-deamino-8-D-arginine vasopressin) to reduce blood loss in uncomplicated cardiac surgery. New Engl J Med 1989; 321: 1437-1443.
12. Brown MR, Swygert TH, Whitten CW, Hebeler R. Desmopressin acetate following cardiopulmonary bypass: evaluation of haemostatic parameters. J Cardiothorac Anaesth 1989; 3: 726-729.
13. Seear MD, Wadsworth LD, Rogers PC, Sheps S, Ashmore PG. The effect of desmopressin acetate (desmopressin) on postoperative blood loss after cardiac operations in children. J Thorac Cardiovas Surg 1989; 98: 217-219.
14. Hedderich GS, Petsikas DJ, Cooper BA et al. Desmopressin acetate in uncomplicated coronary artery bypass surgery: a prospective randomised clinical trial. Can J Surg 1990; 33: 33-36.
15. Anderson TL, Solem JO, Tengborn L, Vinge E. Effects of desmopressin acetate on platelet aggregation, von Willebrand Factor, and blood loss after cardiac surgery with extracorporeal circulation. Circulation 1990; 81: 872-878.
16. Lazenby WD, Russo I, Zadeh BJ et al. Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative haemostasis. Circulation 1990; 82 (IV): 413-419.
17. Frankville DD, Harper GB, Lake CL, John RA. Haemodynamic consequences of desmopressin administration after cardiopulmonary bypass. Anesthesiology 1991; 74: 988-996.
18. Cicero JL III, Massad M, Matano J. Effect of desmopressin acetate on hemorrhage without identifiable cause in coronary artery bypass. Am J Surg 1991; 57: 165-168.
19. Horrow JC, Van Ripper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991; 84: 2063-2070.
20. Ansell J, Klassen V, Lew R et al. Does desmopressin acetate prophylaxis reduce blood loss after valvular heart operations? A randomised double blind study. J Thorac Cardiovasc Surg 1992; 104: 117-123.
21. DeProst D, Barbier-Boehm G, Hazebroucq J et al. Desmopressin has no beneficial effect on excessive postoperative bleeding or blood product requirements associated with cardiopulmonary bypass. Thromb Haemost 1992; 68: 106-110.
22. Mongan PD, Hosking MP. The role of desmopressin acetate in patients undergoing coronary artery bypass surgery. A controlled clinical trial with thromboelastographic risk stratification. Anesthesiology 1992; 77: 38-46.
23. Royston D, Bidstrup BP, Taylor KM, Sapsford RN. Effect of aprotinin on need for blood transfusion after repeat open-heart surgery. Lancet 1987; 2: 1289-1291.
24. Cattaneo M, Mannucci PM. Desmopressin and blood loss after cardiac surgery. Lancet 1993; 342: 812.
25. Rocha E, Hidalgo F, Llorens R, Melero JM, Arroyo JL, Páramo JA. Randomized study of aprotinin and desmopressin to reduce post-operative bleeding after cardiopulmonary bypass surgery. Circulation 1994; 90: 921-927
26. Kobrinsky NL, Letts RM, Patel LR, Israels ED, Monson R, Schwetz N, Cheang MS. Desmopressin decreases blood loss in patients having Harrington rod spinal fusion. Ann Intern Med 1987; 107: 446-450.
27. Guay J, Reinberg C, Poitras B et al. A trial of desmopressin to reduce blood loss in patients undergoing spinal fusion for idiopathic scoliosis. Anesth Analg 1992; 75: 405-410.
28. Lethagen S, Rugarn P, Bernqvist D. Blood loss and safety with desmopressin or placebo during aorto-iliac graft surgery. Eur J Vasc Surg 1991; 5: 173-178.
29. Clagett GP, Valentine RJ, Myers SL, Chervu A, Heller JA. Does desmopressin improve hemostasis and reduce blood loss from aortic surgery? A randomized, double-blind study. J Vasc Surg 1995; 222: 223-230.
30. Ohri SK, Paratt R, Beckett JM, Brannan J, Hunt BJ, Taylor KM. Genetically engineered serine protease inhibitor for haemostasis after cardiac operations. Ann Thorac Surg 1996; 61: 1223-1230.